A comprehensive view of Inflammations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Mount Sinai researchers identify how a family of proteins activate immune cells related to inflammatory bowel disease; discovery may potentially lead to new treatments for conditions such as ulcerative colitis and Crohn's disease

Novartis acquires IFM Therapeutics subsidiary IFM Due for US$90.0M upfront, plus potential milestones totaling US$835.0M; Novartis gets full rights to the STING antagonist program developed in a four-year research collaboration

New findings in food allergies reveal the immunomodulatory role of milk-derived bioactive peptides; the study highlights the potential health benefits of these peptides in regulating inflammatory balance in food allergy: Nanchang University, China

Sun Pharma's US branch recalls 55,272 bottles of febuxostat gout tablets due to microbial contamination at its Dadra, India, manufacturing facility; recall covers 40-milligram and 80-milligram dosages

FDA approves Fresenius Kabi's Tyenne, a biosimilar tocilizumab drug for inflammatory and immune diseases referencing Actemra tocilizumab in both IV and subcutaneous formulations; this marks the company's third biosimilar approval in the US

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count